GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Koninklijke Philips NV (OTCPK:RYLPF) » Definitions » EV-to-EBIT

RYLPF (Koninklijke Philips NV) EV-to-EBIT : 18.68 (As of May. 22, 2025)


View and export this data going back to . Start your Free Trial

What is Koninklijke Philips NV EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Koninklijke Philips NV's Enterprise Value is $29,357 Mil. Koninklijke Philips NV's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was $1,572 Mil. Therefore, Koninklijke Philips NV's EV-to-EBIT for today is 18.68.

The historical rank and industry rank for Koninklijke Philips NV's EV-to-EBIT or its related term are showing as below:

RYLPF' s EV-to-EBIT Range Over the Past 10 Years
Min: -201.55   Med: 24.77   Max: 305.65
Current: 17.99

During the past 13 years, the highest EV-to-EBIT of Koninklijke Philips NV was 305.65. The lowest was -201.55. And the median was 24.77.

RYLPF's EV-to-EBIT is ranked better than
53.93% of 458 companies
in the Medical Devices & Instruments industry
Industry Median: 19.45 vs RYLPF: 17.99

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Koninklijke Philips NV's Enterprise Value for the quarter that ended in Mar. 2025 was $30,431 Mil. Koninklijke Philips NV's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was $1,572 Mil. Koninklijke Philips NV's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 was 5.16%.


Koninklijke Philips NV EV-to-EBIT Historical Data

The historical data trend for Koninklijke Philips NV's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Koninklijke Philips NV EV-to-EBIT Chart

Koninklijke Philips NV Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.42 47.98 -12.47 -111.66 60.21

Koninklijke Philips NV Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -38.77 261.69 107.30 60.21 19.29

Competitive Comparison of Koninklijke Philips NV's EV-to-EBIT

For the Medical Devices subindustry, Koninklijke Philips NV's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Koninklijke Philips NV's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Koninklijke Philips NV's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Koninklijke Philips NV's EV-to-EBIT falls into.


;
;

Koninklijke Philips NV EV-to-EBIT Calculation

Koninklijke Philips NV's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=29356.905/1571.614
=18.68

Koninklijke Philips NV's current Enterprise Value is $29,357 Mil.
Koninklijke Philips NV's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,572 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Koninklijke Philips NV  (OTCPK:RYLPF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Koninklijke Philips NV's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2025 ) =EBIT / Enterprise Value (Q: Mar. 2025 )
=1571.614/30430.70844
=5.16 %

Koninklijke Philips NV's Enterprise Value for the quarter that ended in Mar. 2025 was $30,431 Mil.
Koninklijke Philips NV's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,572 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Koninklijke Philips NV EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Koninklijke Philips NV's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Koninklijke Philips NV Business Description

Address
Philips Center, Amstelplein 2, Amsterdam, NLD, 1096 BC
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (around 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal care products.